  The aim of the present Monte Carlo study is to evaluate the variation of
energy deposition in healthy tissues in the human eye which is irradiated by
brachytherapy sources in comparison with the resultant dose increase in the
gold nanoparticle(GNP)-loaded choroidal melanoma. The effects of these
nanoparticles on normal tissues are compared between 103Pd and 125I as two
ophthalmic brachytherapy sources. Dose distribution in the tumor and healthy
tissues have been taken into account for both mentioned brachytherapy sources.
Also, in a certain point of the eye, the ratio of the absorbed dose by the
normal tissue in the presence of GNPs to the absorbed dose by the same point in
the absence of GNPs has been calculated. In addition, differences observed in
the comparison of simple water phantom and actual simulated human eye in
presence of GNPs are also a matter of interest that have been considered in the
present work. The results show that the calculated dose enhancement factor in
the tumor for 125I is higher than that of the 103Pd. The difference between the
eye globe and the water phantom is more obvious for 125I than that of the 103Pd
when the ophthalmic dosimetry is done in the presence of GNPs. Whenever these
nanoparticles are utilized in enhancing the absorbed dose by the eye tumor, the
use of 125I brachytherapy source will greatly amplify the amount of dose
enhancement factor (DEF) in the tumor site without inflicting much damage to
healthy organs, when compared to the 103Pd source. Furthermore in Monte-Carlo
studies of eye brachytherapy, more precise definition of the eye phantom
instead of a water phantom will become increasingly important when we use 125I
as opposed to when 103Pd is considered.
